# Ruichu Medicine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ruichu-medicine

- Industry: Pharmaceuticals
- Headquarters: Nanjing, China
- Latest round: Series A (Jul 30, 2025)
- Investors on record: 4

## About

Established in 2021 and based in Nanjing, China, Ruichu Medicine is a pharmaceutical company that focuses on developing drugs for degenerative diseases. The company's founding team has more than 10 years of experience in the field of ageing research. In May 2024, it raised over CNY 100 million in pre-series A funding led by new investor Lapam Capital.

The company is dedicated to the development of therapeutic drugs target for degenerative diseases, including neurodegenerative, fibrotic, and inflammatory diseases.

The company generates revenue by providing therapeutic drugs target for degenerative diseases.

The company plans to promote multiple pipeline products into clinical trials and strengthen clinical transformation, and will use pre-series A round funding to promote the clinical filing and development of the company's core projects.

## Funding rounds

- Series A, Jul 30, 2025 — Lapam Capital
- Angel, Jan 3, 2023 — Jolmo Capital, Dynamic Capital, Nanjing Innovation Capital Group

## Investors

- Jolmo Capital (https://capitalatlas.ai/funds/jolmo-capital) — Angel
- Dynamic Capital (https://capitalatlas.ai/funds/dynamic-capital) — Angel
- Nanjing Innovation Capital Group — Angel
- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series A